A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers
PHASE1
The purpose of this study is to evaluate the bioequivalence of fixed dose c...
Motivation to Change, Coping, and Self-Esteem in Adolescent Anorexia Nervosa
N/A
By use of several questionaires, this study aimed at an investigation of th...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT02828956
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
PHASE3
The purpose of this pivotal study is to determine if intravenous Rezafungin...